SEI INVESTMENTS CO - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 103 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.68 and the average weighting 0.1%.

Quarter-by-quarter ownership
SEI INVESTMENTS CO ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$493,990
-19.2%
42,256
-7.1%
0.00%0.0%
Q2 2023$611,474
-50.9%
45,497
-39.4%
0.00%
-50.0%
Q1 2023$1,245,759
+45.6%
75,137
+63.4%
0.00%0.0%
Q4 2022$855,331
-69.6%
45,987
-79.0%
0.00%
-66.7%
Q3 2022$2,816,000
+15.6%
219,452
-37.1%
0.01%
+20.0%
Q2 2022$2,435,000
-0.4%
349,166
+18.1%
0.01%0.0%
Q1 2022$2,445,000
+107.7%
295,714
+70.1%
0.01%
+150.0%
Q4 2021$1,177,000
+27.8%
173,8440.0%0.00%0.0%
Q3 2021$921,000
+1361.9%
173,844
+819.6%
0.00%
Q1 2021$63,0000.0%18,9050.0%0.00%
Q4 2020$63,000
+12.5%
18,9050.0%0.00%
Q3 2020$56,000
-84.3%
18,905
-75.5%
0.00%
-100.0%
Q2 2020$356,000
+19.9%
77,0840.0%0.00%0.0%
Q1 2020$297,000
+518.8%
77,084
+503.7%
0.00%
Q4 2019$48,000
-91.6%
12,768
-88.6%
0.00%
-100.0%
Q1 2019$572,000
+18966.7%
112,169
+8873.5%
0.00%
Q1 2018$3,000
-40.0%
1,2500.0%0.00%
Q4 2017$5,0001,2500.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 213,609$1,446,0002.75%
GABLES CAPITAL MANAGEMENT INC. 449,164$3,041,0001.81%
Prairiewood Capital, LLC 261,403$1,770,0001.40%
ARMISTICE CAPITAL, LLC 9,572,000$64,802,0001.06%
Quantedge Capital Pte Ltd 360,100$2,438,0001.03%
SummerHaven Investment Management, LLC 151,384$1,025,0000.55%
GLOBEFLEX CAPITAL L P 609,030$4,124,0000.42%
EAM Global Investors LLC 347,899$2,355,0000.42%
Lanham O'Dell & Company, Inc. 50,000$339,0000.27%
EAM Investors, LLC 239,071$1,619,0000.27%
View complete list of CATALYST PHARMACEUTICALS INC shareholders